Smith & Nephew PLC reported Q1 2024 revenue of $1,386 million, a 2.9% increase from $1,356 million in Q1 2023. Key areas include Orthopaedics revenue growth of 4.4% and a decline in Advanced Wound Management by 2.0%, with a full-year revenue growth outlook of 5.0% to 6.0%.